News

Bellvitge led the first post-coronavirus clinical trial for the treatment of patients with lung sequelae

The Fibro-Covid clinical trial will evaluate the ability of pirfenidone to prevent the establishment of irreversible and progressive fibrotic lesions in the lungs after overcoming Covid-19 pneumonia.

A web app with IDIBELL participation allows following the global evolution of the Covid-19 pandemic

A team of researchers developed a tool that integrates all epidemiological indicators and compares the evolution between countries.

The HUB-ICO-IDIBELL Biobank responds to the pandemic and creates a collection of COVID-19 samples for research

THE ICO-HUB-IDIBELL Biobank has created a collection of sera, plasma, DNA and RNA samples from patients confirmed by SARS-CoV-2 to make available to the scientific community

The fund against Covid-19 promoted by the ISCIII will finance three IDIBELL projects

The projects focus on the study of the virus biology, the immunity that generates and clinical manifestations of the disease.

Check our open opportunities, meet us at our MSCA-IF bootcamp

IDIBELL is seeking postdoctoral researchers interested in appling to Marie Skłodowska-Curie Actions grant (MSCA-IF). Join us!

Cells of the intestine nervous system and oligodendrocytes are affected in Parkinson’s disease

IDIBELL has participated in a study published in Nature Genetics that describes alterations in the neurons of the intestine and oligodendrocytes in Parkinson’s disease

Students from the “els Jesuïtes de Bellvitge” give their Vodafone Foundation award to IDIBELL

The sustainable development project ‘Junto@s por el clima’ (‘Together for the climate’) designed by the students has been awarded with 5,000 euros, that they have decided to give to IDIBELL.

A study identifies a new treatment of ovarian cancer through its metabolism

DNA repair mechanisms in some ovarian cancer tumors are highly dependent on oxidative metabolism. Process that can be inhibited with drugs like Metformin.

Scroll to Top